Invasive lobular carcinoma of the breast: Patient response to systemic endocrine therapy and hormone response in model systems
Authors:
- Matthew J. SikoraMSMatthew J. Sikora
- Rachel C. JankowitzRJRachel C. Jankowitz
- David J. DabbsDDDavid J. Dabbs
- Steffi OesterreichSOSteffi Oesterreich
Abstract
No abstract availableKeywords
This publication has 77 references indexed in Scilit:
- Whole-genome analysis informs breast cancer response to aromatase inhibitionNature, 2012
- The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroupsNature, 2012
- Invasive lobular breast cancer: subtypes and outcomeBreast Cancer Research and Treatment, 2012
- Adjuvant therapies for special types of breast cancerThe Breast, 2011
- Outcome of special types of luminal breast cancerAnnals of Oncology, 2011
- Lobular invasive carcinoma of the breast is a molecular entity distinct from luminal invasive ductal carcinomaEuropean Journal of Cancer, 2010
- ERRγ Mediates Tamoxifen Resistance in Novel Models of Invasive Lobular Breast CancerCancer Research, 2008
- Lobular and ductal carcinomas of the breast have distinct genomic and expression profilesOncogene, 2008
- A collection of breast cancer cell lines for the study of functionally distinct cancer subtypesCancer Cell, 2006
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences of the United States of America, 2001